News

CHPA files citizen petition to allow liquid APAP dosing recommendations for children 6 months to 2 years

BY Michael Johnsen

WASHINGTON — The Consumer Healthcare Products Association on Monday asked the Food and Drug Administration to take action to ensure that the millions of caretakers who use acetaminophen products in young children have access to convenient and accurate dosing information. Representing makers of over-the-counter single-ingredient liquid acetaminophen medicines for children, CHPA submitted a citizen petition requesting that the FDA publish a “statement of enforcement policy” permitting manufacturers of OTC single-ingredient liquid pediatric acetaminophen products to include dosing information for children ages 6 months to 2 years on the Drug Facts label of these medicines.  

While acetaminophen is approved for use in young children, the currently allowed labeling under tentative final monograph includes only “ask a doctor” in the dosing directions for children ages 6 months to 2 years. 

“The peak of acetaminophen usage in children is for those ages 6 months to 23 months, yet the labeling of these products lacks instructions for this population,” stated Barbara Kochanowski, CHPA VP of regulatory and scientific affairs. “Young children can spike a fever at any time of the day or night, and to get dosing information for children under 2, caretakers must proactively seek out information from a healthcare provider rather than having the convenience of instructions printed on the Drug Facts label," she said. “Providing clear, consistent instructions directly on the label will help ensure that caretakers appropriately dose children under 2 years of age, potentially reducing the likelihood of dosing errors and dosing ‘guesses’ in the middle of the night.” 

In its citizen petition, CHPA requested permission for manufacturers to include pediatric dosing for children ages 6 months to 2 years on product labels moving forward, while rulemaking around the monograph is finalized. CHPA recommended a single, standardized age and weight-based chart — based on the researched and established dosing recommendations of multiple pediatric and primary care medical association treatment guidelines — which all manufacturers could adopt.

In May 2011, a joint FDA Pediatric Advisory Committee and Nonprescription Drugs Advisory Committee unanimously recommended that OTC single-ingredient liquid pediatric acetaminophen products include dosing information for children ages 6 months to 2 years.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

CRN publishes commentary criticizing latest omega-3 research in Natural Medicine Journal

BY Michael Johnsen

WASHINGTON — The limitations within a recent study linking omega-3 fish oil and increased prostate cancer risk ought to be taken in consideration, according to a commentary published in the August issue of Natural Medicine Journal

Published July 11 in the online edition of the Journal of the National Cancer Institute, the report in question suggested that high concentrations of EPA, DPA and DHA — the three anti-inflammatory and metabolically related fatty acids derived from fatty fish and fish-oil supplements — are associated with a 71% increased risk of high-grade prostate cancer. The study also found a 44% increase in the risk of low-grade prostate cancer and an overall 43% increase in risk for all prostate cancers.

According to co-authors Duffy MacKay, the Council for Responsible Nutrition’s VP scientific and regulatory affairs, and Barry Ritz, CRN senior scientific advisory council vice chair, the study was an epidemiological study — meant to generate a hypothesis, not establish a cause-and-effect relationship. However, the study’s researchers intended to look at the relation between selenium and vitamin E supplementation on prostate cancer risk. At no point during the study were the subjects given fish or fish oil supplements. Also, dietary intake of fish or fish oil supplements was not documented, creating no data to back the conclusion that supplemental omega-3 fats are correlated to an increase risk of prostate cancer.

Additionally, MacKay and Ritz noted that the conclusion of the study contradicts the recommendations of reputable health organizations as well as the greater body of scientific evidence which demonstrates the established benefits of both fish and fish oil, saying this study “should not change clinicians’ dietary recommendations or prescribing patterns.”

“With nearly a fifth of all U.S. adults taking omega-3 fish oil supplements each year, it’s not only essential to counter balance the consumer headlines that often make sweeping conclusions,” MacKay said. "But it’s equally important to engage the scientific and clinician communities in a dialogue so that the science is critically interpreted. Part of our role at CRN is to make sure the science is interpreted fairly.”


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

The U.S. Veterans Magazine publishes list of veteran-friendly employers

BY Michael Johnsen

IRVINE, Calif. — The Exchange, Safeway and Walmart were among the companies identified as the nation’s top veteran-friendly companies by the U.S. Veterans Magazine last week. The publication released the results of its 2013 evaluation of the nation’s top veteran-friendly companies, which also included 3M, the Coca-Cola Company, Kellogg Co., Novartis, Sears Holdings and Target, following a poll of Fortune 1000 companies.  

“It is our firm belief that veterans possess the character, discipline and skills that every business can profit from,” stated Mona Lisa Faris, president and publisher of the U.S. Veterans Magazine. “This magazine was created to support our troops, and we at USVM are proud to recognize other businesses that are also making veterans a priority.”

The annual review is an evaluation of the nation’s employers, initiatives, government agencies and educational institutions. The goal of the annual evaluations is to not only bring the latest information and guidance to readers, the publication stated, but also to encourage active outreach and diversity policies among corporations and government agencies. 

The lists were compiled from market research, independent research, diversity conference participation and survey responses that were performed by DiversityComm’s agents and/or affiliates. This year, more than 250 companies and institutions participated.

The results are published in the summer issue of the U.S. Veterans Magazine, featuring Bill Cosby as the cover story and available on newsstands on Aug. 15.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?